Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells

Published:2013-08 Issue:8 Volume:45 Page:e38-e38
ISSN:1226-3613
Container-title:Experimental & Molecular Medicine
language:en
Short-container-title:Exp Mol Med

Author:

Cheol Son Ju,Woo Kang Dong,Mo Yang Kwang,Choi Kang-Yell,Gen Son Tae,Min Do Sik

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://www.nature.com/articles/emm201375.pdf

Reference24 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics. CA Cancer J Clin 2008; 58: 71–96.

2. Candelaria M, Garcia-Arias A, Cetina L, Duenas-Gonzalez A . Radiosensitizers in cervical cancer: cisplatin and beyond. Radiat Oncol 2006; 1: 15–31.

3. Selvy PE, Lavieri RR, Lindsley CW, Brown HA . Phospholipase D: enzymology, functionality, and chemical modulation. Chem Rev 2011; 111: 6064–6119.

4. Huang P, Frohman MA . The potential for phospholipase D as a new therapeutic target. Expert Opin Ther Targets 2007; 11: 707–716.

5. Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL et al. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol 2009; 5: 108–117.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A positive feedback loop between PLD1 and NF-κB signaling promotes tumorigenesis of nasopharyngeal carcinoma;Journal of Genetics and Genomics;2024-06

2. The p53/ZEB1-PLD3 feedback loop regulates cell proliferation in breast cancer;Cell Death & Disease;2023-11-17

3. Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma;Cancer Biology & Medicine;2023-06-27

4. P38 MAPK and Radiotherapy: Foes or Friends?;Cancers;2023-01-30

5. The role of phospholipase D in breast cancer;Phospholipases in Physiology and Pathology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3